A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Simon Cancer Center, Indiana University School of Medicine, Indianapolis.
B H
BH
O'Neil
University of Colorado, Denver, Aurora.
A J
AJ
Scott
Roswell Park Cancer Institute, Buffalo.
W W
WW
Ma
Fox Chase Cancer Center, Philadelphia.
S J
SJ
Cohen
New York University, New York.
L
L
Leichman
University of Colorado, Denver, Aurora.
D L
DL
Aisner
Kaiser Permanente, Lone Tree.
A R
AR
Menter
University of Rochester Medical Center, Rochester.
M A
MA
Tejani
Oncare Hawaii, Honolulu.
J K
JK
Cho
Cone Health Cancer Center, Greensboro.
J
J
Granfortuna
University of Washington, Seattle.
L
L
Coveler
University of Cincinnati Cancer Institute, Cincinnati.
O O
OO
Olowokure
University of Kansas Medical Center, Westwood.
J C
JC
Baranda
Mount Sinai Medical Center, Miami Beach.
M
M
Cusnir
Karmanos Cancer Institute, Detroit.
P
P
Phillip
Rex Cancer Center UNC Healthcare, Raleigh.
J
J
Boles
Carolinas Health Care, Charlotte.
R
R
Nazemzadeh
Kaiser Permanante Northwest, Portland.
M
M
Rarick
NYU Clinical Cancer Center, New York.
D J
DJ
Cohen
Hendersonville Hematology and Oncology at Pardee, Hendersonville.
J
J
Radford
Kaiser Permanante Medical Center, Vallejo.
L
L
Fehrenbacher
McLeod Regional Medical Center, Florence.
R
R
Bajaj
University of Massachusetts Memorial, Worcester.
V
V
Bathini
UCSD Moores Cancer Center, La Jolla.
P
P
Fanta
Vanderbilt-Ingram Cancer Center, Nashville.
J
J
Berlin
UNC Lineberger Comprehensive Cancer Center, Chapel Hill.
A J
AJ
McRee
Onconova Therapeutics Inc., Newtown.
R
R
Maguire
Onconova Therapeutics Inc., Newtown.
F
F
Wilhelm
Onconova Therapeutics Inc., Newtown.
M
M
Maniar
University of Colorado, Denver, Aurora.
A
A
Jimeno
Oncology Consortia of Criterium Inc., Saratoga Springs, USA.
C L
CL
Gomes
University of Colorado, Denver, Aurora.
W A
WA
Messersmith